Cargando…

Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women

OBJECTIVE: To study the presence of viral RNA in the follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women undergoing assisted reproductive technology (ART). DESIGN: Prospective, single-center, observational study. SETTING: Tertiary hospital. PATIENT(S): A tota...

Descripción completa

Detalles Bibliográficos
Autores principales: Boudry, Liese, Essahib, Wafaa, Mateizel, Ileana, Van de Velde, Hilde, De Geyter, Deborah, Piérard, Denis, Waelput, Wim, Uvin, Valerie, Tournaye, Herman, De Vos, Michel, De Brucker, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719925/
https://www.ncbi.nlm.nih.gov/pubmed/35272846
http://dx.doi.org/10.1016/j.fertnstert.2021.12.032
_version_ 1784625040402153472
author Boudry, Liese
Essahib, Wafaa
Mateizel, Ileana
Van de Velde, Hilde
De Geyter, Deborah
Piérard, Denis
Waelput, Wim
Uvin, Valerie
Tournaye, Herman
De Vos, Michel
De Brucker, Michael
author_facet Boudry, Liese
Essahib, Wafaa
Mateizel, Ileana
Van de Velde, Hilde
De Geyter, Deborah
Piérard, Denis
Waelput, Wim
Uvin, Valerie
Tournaye, Herman
De Vos, Michel
De Brucker, Michael
author_sort Boudry, Liese
collection PubMed
description OBJECTIVE: To study the presence of viral RNA in the follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women undergoing assisted reproductive technology (ART). DESIGN: Prospective, single-center, observational study. SETTING: Tertiary hospital. PATIENT(S): A total of 16 patients undergoing transvaginal oocyte retrieval who had a positive SARS-CoV-2 RNA test <48 hours before the procedure. All patients underwent the retrieval between September 2020 and June 2021 and used in vitro fertilization or intracytoplasmic sperm injection. All embryos were vitrified to avoid conception during SARS-CoV-2 infection. INTERVENTION(S): Follicular fluid aspirated during oocyte retrieval, cumulus cells, and endometrial samples were analyzed for SARS-CoV-2 RNA using the RealStar SARS-CoV-2 RT-PCR-Kit1.0. MAIN OUTCOME MEASURE(S): The primary outcome parameter was the detection of viral RNA in the follicular fluid, cumulus cells, and endometrial cells. Fertilization rate, embryo developmental potential, and clinical outcome after frozen embryo transfer were secondary outcome parameters. RESULT(S): Samples from 16 patients were analyzed. Cycle threshold values of <40 were considered positive. All samples were negative for SARS-CoV-2 viral RNA. No inflammatory lesions of the endometrium were identified histologically. Fertilization rate, embryo development, and clinical outcomes after embryo transfer were reassuring. CONCLUSION(S): In women infected with SARS-CoV-2 who underwent ART, viral RNA was undetectable in the follicular fluid, cumulus cells, and endometrium. Caution is warranted in view of the small sample size, and the risk of SARS-CoV-2 affecting the embryo via ART cannot be ruled out. Adequate counseling of women and couples undergoing ART is crucial in parallel with further research on the effect of exposure of the early human embryo to SARS-CoV-2. CLINICAL TRIAL REGISTRATION NUMBER: NCT04425317.
format Online
Article
Text
id pubmed-8719925
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine
record_format MEDLINE/PubMed
spelling pubmed-87199252022-01-03 Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women Boudry, Liese Essahib, Wafaa Mateizel, Ileana Van de Velde, Hilde De Geyter, Deborah Piérard, Denis Waelput, Wim Uvin, Valerie Tournaye, Herman De Vos, Michel De Brucker, Michael Fertil Steril Original Article OBJECTIVE: To study the presence of viral RNA in the follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women undergoing assisted reproductive technology (ART). DESIGN: Prospective, single-center, observational study. SETTING: Tertiary hospital. PATIENT(S): A total of 16 patients undergoing transvaginal oocyte retrieval who had a positive SARS-CoV-2 RNA test <48 hours before the procedure. All patients underwent the retrieval between September 2020 and June 2021 and used in vitro fertilization or intracytoplasmic sperm injection. All embryos were vitrified to avoid conception during SARS-CoV-2 infection. INTERVENTION(S): Follicular fluid aspirated during oocyte retrieval, cumulus cells, and endometrial samples were analyzed for SARS-CoV-2 RNA using the RealStar SARS-CoV-2 RT-PCR-Kit1.0. MAIN OUTCOME MEASURE(S): The primary outcome parameter was the detection of viral RNA in the follicular fluid, cumulus cells, and endometrial cells. Fertilization rate, embryo developmental potential, and clinical outcome after frozen embryo transfer were secondary outcome parameters. RESULT(S): Samples from 16 patients were analyzed. Cycle threshold values of <40 were considered positive. All samples were negative for SARS-CoV-2 viral RNA. No inflammatory lesions of the endometrium were identified histologically. Fertilization rate, embryo development, and clinical outcomes after embryo transfer were reassuring. CONCLUSION(S): In women infected with SARS-CoV-2 who underwent ART, viral RNA was undetectable in the follicular fluid, cumulus cells, and endometrium. Caution is warranted in view of the small sample size, and the risk of SARS-CoV-2 affecting the embryo via ART cannot be ruled out. Adequate counseling of women and couples undergoing ART is crucial in parallel with further research on the effect of exposure of the early human embryo to SARS-CoV-2. CLINICAL TRIAL REGISTRATION NUMBER: NCT04425317. Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine 2022-04 2022-01-01 /pmc/articles/PMC8719925/ /pubmed/35272846 http://dx.doi.org/10.1016/j.fertnstert.2021.12.032 Text en ©2022 Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Boudry, Liese
Essahib, Wafaa
Mateizel, Ileana
Van de Velde, Hilde
De Geyter, Deborah
Piérard, Denis
Waelput, Wim
Uvin, Valerie
Tournaye, Herman
De Vos, Michel
De Brucker, Michael
Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women
title Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women
title_full Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women
title_fullStr Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women
title_full_unstemmed Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women
title_short Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2–positive women
title_sort undetectable viral rna in follicular fluid, cumulus cells, and endometrial tissue samples in sars-cov-2–positive women
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719925/
https://www.ncbi.nlm.nih.gov/pubmed/35272846
http://dx.doi.org/10.1016/j.fertnstert.2021.12.032
work_keys_str_mv AT boudryliese undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen
AT essahibwafaa undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen
AT mateizelileana undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen
AT vandeveldehilde undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen
AT degeyterdeborah undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen
AT pierarddenis undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen
AT waelputwim undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen
AT uvinvalerie undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen
AT tournayeherman undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen
AT devosmichel undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen
AT debruckermichael undetectableviralrnainfollicularfluidcumuluscellsandendometrialtissuesamplesinsarscov2positivewomen